JP2017025053A - Medicinal effects of mugwort leaf juice - Google Patents

Medicinal effects of mugwort leaf juice Download PDF

Info

Publication number
JP2017025053A
JP2017025053A JP2015169768A JP2015169768A JP2017025053A JP 2017025053 A JP2017025053 A JP 2017025053A JP 2015169768 A JP2015169768 A JP 2015169768A JP 2015169768 A JP2015169768 A JP 2015169768A JP 2017025053 A JP2017025053 A JP 2017025053A
Authority
JP
Japan
Prior art keywords
leaf juice
mugwort leaf
medicinal effects
neuralgia
headache
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015169768A
Other languages
Japanese (ja)
Inventor
哲夫 東倉
Tetsuo Higashikura
哲夫 東倉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2015169768A priority Critical patent/JP2017025053A/en
Publication of JP2017025053A publication Critical patent/JP2017025053A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for completely curing intractable diseases.SOLUTION: According to the present invention, a mugwort leaf juice is administered against stiff muscles pain, neuralgia, rheumatism, arthralgia, headache, or epidemic parotitis.SELECTED DRAWING: None

Description

現今の医術では解明完治せぬ疾病があったThere was a disease that could not be completely cured by current medical techniques

蓬葉汁を服用するTake Aoba Soup

苦痛難渋の疾病が完治するThe painful and painful diseases are completely cured

医業薬業に貢献利用可能である．It can be used to contribute to the pharmaceutical industry.

Claims (1)

蓬葉汁を服用し疾病を完治する疾病名
疑固筋肉痛．神経痛 リューマチ 関節痛 頭痛．オタフク風．Suspected muscular pain that is completely cured by taking koji leaf juice. Neuralgia Rheumatoid joint pain Headache. Otafuku style.
JP2015169768A 2015-07-21 2015-07-21 Medicinal effects of mugwort leaf juice Pending JP2017025053A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015169768A JP2017025053A (en) 2015-07-21 2015-07-21 Medicinal effects of mugwort leaf juice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015169768A JP2017025053A (en) 2015-07-21 2015-07-21 Medicinal effects of mugwort leaf juice

Publications (1)

Publication Number Publication Date
JP2017025053A true JP2017025053A (en) 2017-02-02

Family

ID=57949695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015169768A Pending JP2017025053A (en) 2015-07-21 2015-07-21 Medicinal effects of mugwort leaf juice

Country Status (1)

Country Link
JP (1) JP2017025053A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625003A (en) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk Galenical drug-containing antiviral agent
JPH08107779A (en) * 1994-10-11 1996-04-30 Chojiro Noguchi Mugwort juice for healthy beverage and its production
JP2005022988A (en) * 2003-06-30 2005-01-27 Takeda Food Products Ltd Composition for promoting sugar transport of muscle cell comprising mugwort as active ingredient
JP2008050301A (en) * 2006-08-24 2008-03-06 Prima Meat Packers Ltd Pancreatic lipase inhibitor
WO2011149025A1 (en) * 2010-05-28 2011-12-01 株式会社上野忠 Body temperature rising agent for oral administration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625003A (en) * 1992-04-27 1994-02-01 Showa Shell Sekiyu Kk Galenical drug-containing antiviral agent
JPH08107779A (en) * 1994-10-11 1996-04-30 Chojiro Noguchi Mugwort juice for healthy beverage and its production
JP2005022988A (en) * 2003-06-30 2005-01-27 Takeda Food Products Ltd Composition for promoting sugar transport of muscle cell comprising mugwort as active ingredient
JP2008050301A (en) * 2006-08-24 2008-03-06 Prima Meat Packers Ltd Pancreatic lipase inhibitor
WO2011149025A1 (en) * 2010-05-28 2011-12-01 株式会社上野忠 Body temperature rising agent for oral administration

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"ヨモギ（フーチバー）健康食品商品リスト", [ONLINE], JPN6016044747, 28 December 2004 (2004-12-28), ISSN: 0003443630 *
GREEN SKETCH（グリーンスケッチ）[ONLINE], vol. No.8 2000夏号, JPN6016044751, 2000, ISSN: 0003443632 *
鈴木 長明，真秀 重成: "モンゴル遊牧地域における除痛に関する伝統的民間療法の現地調査", 日本歯科麻酔学会雑誌, vol. 第３８巻，第５号, JPN6016044750, 2010, pages 575 - 579, ISSN: 0003443631 *

Similar Documents

Publication Publication Date Title
MX2022001755A (en) Cyclic di-nucleotide compounds and methods of use.
EA201800199A1 (en) APPLICATION OF AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OF METABOLIC DISORDERS, INCREASE ENERGY CONSUMPTION AND WEIGHT REDUCTION, COMPOSITIONS, MEDICINE
CY1121698T1 (en) LIQUID INHALATION PREPARATION CONTAINING RPL554
CL2019001685A1 (en) Amino acid compositions and methods for the treatment of diseases and muscular disorders.
PH12015501740A1 (en) Sodium channel modulators for the treatment of pain
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
EA201590655A1 (en) COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
SG11201609014TA (en) Gpc3 -targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
EA201590654A1 (en) COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE
EA201391737A1 (en) NEW CONNECTIONS AS DIACYLGLYCEROLACILTRANSFERASE INHIBITORS
MX2018006247A (en) Methods for treating alzheimer's disease and related disorders.
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
MY196979A (en) Method of treating disease by auricular anesthesia of cranial nerves
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
FR3017624B1 (en) PREDICTIVE METHOD FOR CHARACTERIZING THE RADIOSENSITIVITY AND TISSUE REACTION OF A PATIENT TO THERAPEUTIC IONIZING RADIATION
EA201691299A1 (en) APPLICATION OF LACHINIMODA TO SLOW DOWN THE PROGRESSION OF HANTINGTON'S DISEASE
BR112015028249A2 (en) active substance for the treatment of sarcopenia
EA201391724A1 (en) NEW CONNECTIONS AS INHIBITORS DIACYLGLYCERIN ACYLTRANSFERASE INHIBITORS
JP2017025053A (en) Medicinal effects of mugwort leaf juice
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
MX2018011607A (en) Sultiame for the treatment of sleep apnea.
JP2015524464A5 (en)
RU2015131803A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
UA96223U (en) A method of treating patients with chronic obstructive pulmonary disease combined with depressive episode
Kar et al. Perception of nursing students on human rabies and its prevention-a study conducted in a nursing school of Odisha

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161129

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170613